Mesenchymal stem cell alleviate concanavalin A-induced hepatitis via immune reprogramming and complement regulation

• by Hanpeng Luo, Bing Liu, Yaqin Li, Peng Cui, Tao Zhou, Cai Ye, Can Wu, Junchang Wu, Yu Wang, Wei V. Zheng

• May 13, 2026

Pembrolizumab-associated immune-related hepatitis: a retrospective case report analysis

• by Ke-qian Chen, Yang Chen, Jing-Fu Peng, Yi Huang, Xiang Liu

• June 17, 2026

Who Decides When a Doctor Steps Back?

Cognitive decline, credentialing, and why “I’ll know” often isn’t enough.

• by Paula Span

• February 4, 2026

• 7 min

AI Scribes: Efficiency for Whom?

Unresolved safety, privacy, and regulatory concerns may limit benefits of AI scribes for physicians and patients.

• by Kathryn Wighton

• January 27, 2026

• 3 min